Shire announced better-than-expected quarterly earnings, but Wall Street focused on its potential neuroscience spinout. Drugs to treat attention deficit hyperactivity disorder (ADHD) have been a ...

The meadow will be a fantastic sources for pollen and nectar, says Cambridge college gardener.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Analysts agree that another bidder for Shire is unlikely to emerge at this point. (Shire) We have a deal—a preliminary one, at least. Late Tuesday, after a fifth buyout offer from Takeda, Shire said ...

LONDON (Reuters) - Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French ...

Belgian aviation support brand Shire is hoping to change the airport ground support equipment (GSE) game with a line of purpose-built baggage and cargo tractors engineered from the ground up as ...

Shire PLC is buying NPS Pharmaceuticals Inc., a maker of treatments for rare diseases, for $5.2 billion, returning to deal-making with the help of the breakup fee it received from one-time suitor ...